BAM
ARCT icon

Byrne Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Byrne Asset Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,050
Closed -$111K – 568
2025
Q4 		$111K Buy
18,050
+17,650
+4,413% +$191K 0.06% 208
2025
Q3 		$7.37K Sell
400
-2,563
-87% -$41.2K ﹤0.01% 438
2025
Q2 		$38.5K Buy
+2,963
New +$35K 0.03% 286
2025
Q1 		– Sell
-1,520
Closed -$24.1K – 292
2024
Q4 		$25.8K Sell
1,520
-560
-27% -$10.5K 0.02% 257
2024
Q3 		$48.3K Buy
2,080
+240
+13% +$5.13K 0.03% 204
2024
Q2 		$45K Sell
1,840
-220
-11% -$6.67K 0.03% 210
2024
Q1 		$69.6K Sell
2,060
-270
-12% -$9.57K 0.05% 183
2023
Q4 		$76.3K Sell
2,330
-940
-29% -$22.3K 0.06% 165
2023
Q3 		$84K Sell
3,270
-230
-7% -$7.08K 0.07% 154
2023
Q2 		$100K Sell
3,500
-700
-17% -$19.1K 0.07% 193
2023
Q1 		$101K Sell
4,200
-2,315
-36% -$41.5K 0.07% 177
2022
Q4 		$110K Buy
6,515
+1,995
+44% +$34.8K 0.08% 171
2022
Q3 		$67K Buy
4,520
+370
+9% +$6.21K 0.05% 187
2022
Q2 		$74K Buy
4,150
+150
+4% +$2.94K 0.05% 163
2022
Q1 		$108K Buy
4,000
+910
+29% +$23.2K 0.07% 154
2021
Q4 		$114K Buy
+3,090
New +$126K 0.07% 153

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Byrne Asset Management's ARCT Position: Q1 2026 in Review

Byrne Asset Management sold out of Arcturus Therapeutics (ARCT) in Q1 2026, closing a stake of 18,050 shares — an estimated $111K sold.

Byrne Asset Management first reported a position in ARCT in Q4 2021 and held it in 16 quarters. The position peaked at $114K in Q4 2021. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

  • Byrne Asset Management reported no remaining Arcturus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Byrne Asset Management sold 18,050 Arcturus Therapeutics shares in Q1 2026, an estimated $111K.
  • Byrne Asset Management first reported a position in Arcturus Therapeutics in Q4 2021 and held it in 16 quarters.
  • Byrne Asset Management's Arcturus Therapeutics position peaked at $114K in Q4 2021.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on Byrne Asset Management's 13F filing for Q1 2026, filed 2 Apr 2026.